|Table of Contents|

Analysis on the quality and diagnostic level of cervical cytology liquid-based preparation in 39 medical institutions in Shaanxi Province

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 19
Page:
3661-3664
Research Field:
Publishing date:

Info

Title:
Analysis on the quality and diagnostic level of cervical cytology liquid-based preparation in 39 medical institutions in Shaanxi Province
Author(s):
ZHANG Lanlan1; 2; YANG Qiao2; YANG Li3; CHEN Jia2; GUO Ying2; 4
1.School of Basic Medicine,Xi’an Jiaotong University,Shaanxi Xi’an 710065,China;2.Department of Pathology,Xi’an Daxing Hospital,Shaanxi Xi’an 710016,China；3.Department of Pathology,the First Affiliated Hospital of the Air Force Medical University(Xijing Hospital),Shaanxi Xi’an 710032,China;4.Northwestern University School of Medicine，Shaanxi Xi’an 710069,China.
Keywords:
cervical cytology; liquid-based thin layer preparation techology; diagnosis; status analysis
PACS:
R730.4
DOI:
10.3969/j.issn.1672-4992.2024.19.006
Abstract:
Objective:To investigate the current status of cervical cytology liquid-based preparation and diagnosis in the pathology departments of hospitals at all levels in Shaanxi Province,and to provide a basis for strengthening the standardization of cervical cancer screening.Methods:Relying on Shaanxi International Medical Exchange and Promotion Association,external quality assessment(EQA) of cervical cytology liquid-based preparation and diagnosis was carried out.At the same time,the current status of cervical cytology liquid-based preparation and diagnosis in pathology departments of hospitals at all levels in Shaanxi Province was investigated.To analyze and compare the excellent and good rate of cervical cytology liquid-based preparation and the accuracy rate of diagnosis in hospital at all levels.Results:The quality data of cervical cytology liquid based preparation and diagnosis of 39 medical institutions at all levels in Shaanxi Province were included in the statistical analysis.According to the "Cytology External Quality Assessment Criteria",there were 18 medical institutions with scores above 900(accounting for 46%),13 medical institutions with scores between 800 and 900(accounting for 33%),and 7 medical institutions with scores between 600 and 800(qualified),accounting for 17.9%,and 1 medical institution was below 600 points(accounting for 2.5%).The excellent and good rate was 79%,and the qualified rate was 97%.The excellent and good rate was 60% in the grade A secondary hospital and 84.6% in the grade A teriary hospital.Conclusion:The liquid-based cervical cytology preparation and diagnosis in the pathology departments of the tertiary hospitals in Shaanxi Province are relatively standardized.The excellent and good rate and diagnostic accuracy of the liquid-based cervical cytology preparation in the secondary hospitals need to be improved,and the relevant departments need to carry out standardized training of the liquid-based cervical cytology preparation and diagnosis.

References:

[1]蔡会龙,原伟光,孙惠昕,等.全球及我国宫颈癌流行现状及防治策略［J］.临床肿瘤学杂志,2023,28(1):90-93.CAI HL,YUAN WG,SUN HX,et al.Prevalence and prevention strategies of cervical cancer in the world and China［J］.Chinese Clinical Oncology,2023,28(1):90-93.
[2]SINGH D,VIGNAT J,LORENZONI V,et al.Global estimates of incidence and mortality of cervical cancer in 2020:a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative［J］.Lancet Glob Health,2023,2:197-206.
[3]ICO HPV Information Centre.Human papillomavirus and related diseases report［R］.Spain:Institut Catalàd’Oncologia:2019.
[4]黄留叶.宫颈癌可防可控,中国HPV疫苗或将惠及非洲国家［J］.国际人才交流,2021(5):48-50.HUANG LY.Cervical cancer is preventable and controllable,and China’s HPV vaccine may benefit African countries［J］.International talent exchange,2021(5):48-50.
[5]潘锋.推进三级预防策略,推动《加速消除宫颈癌全球战略》［J］.中国当代医药,2021,28(7):1-3.PAN F.Promote the tertiary prevention strategy and promote the Global Strategy to Accelerating the Elimination of Cervical Cancer［J］.Contemporary Medicine in China,2021,28(7):1-3.
[6]中华医学会.《临床技术操作规范·病理学分册》［M］.北京:人民军医出版社，2004:13-15.Chinese Medical Association.Clinical technical operation specifications·Section of Pathology［M］.Beijing:People’s Military Medical Press,2004:13-15.
[7]卫办医政发［2009］ 31号.病理科建设与管理指南［S］.中国：中华人民共和国国家卫生健康委员会公报，2009.The Health Office is responsible for medical affairs［2009］ 31 number.Guidelines for the construction and management of the pathology department［S］.China:National Health Commission of the People’s Republic of China,2009.
[8]马博文,何伟华《子宫颈细胞病理学诊断图谱》第2版［M］.北京:人民军医出版社,2013:14.MA BW,HE WH.Diagnostic atlas of cervical cytological pathology,2nd edition［M］.Beijing:People’s MilitaryMedical Press,2013:14.
[9]马博文.《子宫颈与子宫细胞病理学诊断图谱》第1版［M］.北京:化学工业出版社,2021:17-18.MA BW.Diagnostic atlas of cervical and uterine cytopathology,1nd edition［M］.Beijing:Chemical Industry Press,2021:17-18.
[10]李文军.基层医院病理科的现状与发展思路［J］.临床合理用药杂志,2012,5(27):160.LI WJ.The current situation and development ideas of the Pathology Department in primary hospitals［J］.Journal of Clinical Rational Drug Use,2012,5(27):160.
[11]许军鹏,李明阳,马静,等.陕西省病理科现状的普查与思考［J］.中华病理学杂志,2021,50(12):1428-1432.XU JP,LI MY,MA J,et al.Survey and thinking on the current situation of the Pathology Department in Shaanxi Province［J］.Chinese Journal of Pathology,2021,50(12):1428-1432.
[12]杨野梵,武莎斐,李媛,等.2019-2020年中国病理科人员、设备、工作量的调研报告［J］.中华病理学杂志,2023,52(9):985-988.YANG YF,WU SF,LI Y,et al.Research report on personnel,equipment and workload of Chinese Pathology Department in 2019-2020［J］.Chinese Journal of Pathology,2021,50(12):985-988.
[13]乔丽葵.病理科医技人员健康状况的初步调查［J］.中华劳动卫生职业病杂志,2016,34(6):454.QIAO LK.Preliminary investigation of the health status of medical technicians in the pathology department［J］.Chinese Journal of Labor Health and Occupational Diseases,2016,34(6):454.
[14] 倪型灏,孙文勇,余传定.浙江省二级及以下医院病理科质量控制现状的调研及对中小医院病理科发展的思考［J］.中华病理学杂志,2007,36(8):575-576.NI XH,SUN WY,YU CD.Research on the quality control of pathology department in secondary and lower hospitals in Zhejiang Province and thinking on its development in small and medium-sized hospitals in Zhejiang Province［J］.Chinese Journal of Pathology,2007,36(8):575-576.
[15] FERRALL L,LIN KY,RODEN RBS,et al.Cervical cancer immunotherapy:Facts and hopes［J］.Clin Cancer Res,1970,18:4953-4973.
[16] RAHANGDALE L,MUNGO C,O’ CONNOR S,et al.Human papillomavirus vaccination and cervical cancer risk［J］.BMJ,2022,15:379.
[17] PERKINS RB,WENTZENSEN N,GUIDO RS,et al.Cervical cancer screening:A review［J］.JAMA,2023,6:547-558.

Memo

Memo:
-
Last Update: 2024-08-30